Definition/General
Introduction:
A foreign body reaction in the breast is an inflammatory response to exogenous material, such as silicone from breast implants, suture material, or injected substances
It is a benign, non-neoplastic process.
Origin:
It is caused by the introduction of foreign material into the breast tissue.
Classification:
It is a type of granulomatous inflammation.
Epidemiology:
It is most common in women with a history of breast surgery, implants, or injections.
Clinical Features
Presentation:
Can present as a firm, palpable mass, skin changes, or pain
It can mimic malignancy.
Symptoms:
A breast lump is the most common symptom
It can be associated with pain and tenderness.
Risk Factors:
History of breast implants, injections (e.g., silicone, paraffin), or surgery.
Screening:
Mammography can show a mass, architectural distortion, or calcifications.
Master Foreign Body Reaction Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
An ill-defined, firm, fibrotic area
Cystic spaces containing foreign material may be present.
Characteristics:
The tissue is often indurated and white-gray.
Size Location:
Size and location depend on the site of the foreign material.
Multifocality:
Can be multifocal.
Microscopic Description
Histological Features:
The key feature is a granulomatous inflammatory reaction centered around the foreign material
The infiltrate is composed of macrophages, multinucleated giant cells (foreign body type), lymphocytes, and plasma cells
The foreign material itself may be visible (e.g., silicone vacuoles, suture material).
Cellular Characteristics:
The giant cells are large and contain multiple, haphazardly arranged nuclei.
Architectural Patterns:
A granulomatous and fibrotic response is characteristic.
Grading Criteria:
This is a benign inflammatory process.
Immunohistochemistry
Positive Markers:
Not typically required for diagnosis.
Negative Markers:
Not typically required for diagnosis.
Diagnostic Utility:
IHC is not used for diagnosis.
Molecular Subtypes:
Molecular subtyping is not relevant for this benign condition.
Molecular/Genetic
Genetic Mutations:
This is a benign condition and is not associated with specific genetic mutations.
Molecular Markers:
No specific molecular markers are routinely used for diagnosis.
Prognostic Significance:
This is a benign condition
However, there is a rare association between breast implants and anaplastic large cell lymphoma (BIA-ALCL).
Therapeutic Targets:
Treatment may involve surgical excision of the affected tissue.
Differential Diagnosis
Similar Entities:
Invasive carcinoma
Fat necrosis
Infectious granulomatous mastitis (e.g., tuberculosis).
Distinguishing Features:
Invasive carcinoma is composed of malignant epithelial cells
Fat necrosis has foamy macrophages and anucleated adipocytes
Infectious granulomas may show caseous necrosis and specific microorganisms.
Diagnostic Challenges:
The main challenge is to identify the foreign material and to exclude malignancy, which can be mimicked clinically and radiologically.
Rare Variants:
There are no specific rare variants.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
[specimen type], measuring [size] cm in greatest dimension
Diagnosis
[diagnosis name]
Classification
Classification: [classification system] [grade/type]
Histological Features
Shows [architectural pattern] with [nuclear features] and [mitotic activity]
Size and Extent
Size: [X] cm, extent: [local/regional/metastatic]
Margins
Margins are [involved/uninvolved] with closest margin [X] mm
Lymphovascular Invasion
Lymphovascular invasion: [present/absent]
Lymph Node Status
Lymph nodes: [X] positive out of [X] examined
Special Studies
IHC: [marker]: [result]
Molecular: [test]: [result]
[other study]: [result]
Final Diagnosis
Final diagnosis: [complete diagnosis]